Rein Therapeutics, Inc. · NASDAQ:RNTX
Rein Therapeutics, Inc. shareholders
As of Sep 30, 2026, 62 institutions reported holding Rein Therapeutics, Inc., 47.7% of its shares. Largest: Voss Capital, LP, Cable Car Capital, LP and ADAR1 Capital Management, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Rein Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Voss Capital, LP | 5.85M | 6.8% | +588K | Nov 16, 2026 |
| Cable Car Capital, LP | 5.2M | 6.0% | no change | Nov 16, 2026 |
| ADAR1 Capital Management, LLC | 4.5M | 5.2% | no change | Nov 16, 2026 |
| Vanguard | 3.9M | 4.5% | +123K | Nov 13, 2026 |
| BIOS Capital Management, LP | 2.98M | 3.5% | no change | Nov 13, 2026 |
| Ikarian Capital, LLC | 2.95M | 3.4% | no change | Nov 16, 2026 |
| Citadel | 2.57M | 3.0% | +128K | Nov 16, 2026 |
| Velan Capital Investment Management LP | 1.7M | 2.0% | no change | Nov 16, 2026 |
| Great Point Partners LLC | 1.66M | 1.9% | −912K | Nov 16, 2026 |
| Prosight Management, LP | 1.66M | 1.9% | +560K | Nov 13, 2026 |